Verified Nov 2026
Electronics & Software
·

Orlando, Florida
·
Since 2004
Lensar, Inc. is a medical device company headquartered in Orlando, Florida, founded in 2004. It employs roughly 100 to 200 people and is publicly traded on NASDAQ under the ticker LNSR. The company makes robotic femtosecond laser systems used in refractive eye surgery, serving ophthalmologists and surgical centers. Its flagship offerings include the LENSAR Laser System and the ALLY Robotic Cataract Laser System. In March 2026, Alcon and LENSAR agreed to terminate a merger agreement.
Lensar, Inc. at a glance
Revenue
58.4M
Employees
100-200
Founded
2004
Headquarters
Orlando, Florida
Ownership
Publicly traded (NASDAQ: LNSR)
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Lensar, Inc. is a medical device company headquartered in Orlando, Florida, founded in 2004. It employs roughly 100 to 200 people and is publicly traded on NASDAQ under the ticker LNSR. The company makes robotic femtosecond laser systems used in refractive eye surgery, serving ophthalmologists and surgical centers. Its flagship offerings include the LENSAR Laser System and the ALLY Robotic Cataract Laser System. In March 2026, Alcon and LENSAR agreed to terminate a merger agreement.
At a glance
Attribute | Detail |
|---|---|
Founded | 2004 |
Headquarters | Orlando, Florida |
Employees | 100-200 |
Revenue | 58.4M |
Ownership | Publicly traded (NASDAQ: LNSR) |
Primary capability | Electronics & Software |
What Lensar, Inc. makes
The company offers the ALLY Robotic Cataract Laser System, which is designed for sterile cataract surgery in a single operating room, along with a Patient Interface Device and related training and maintenance services.
Latest developments
2026-08-13 — LENSAR® Reports Second Quarter 2026 Results and Provides (globenewswire.com)
2026-05-08 — LENSAR® Reports First Quarter 2026 Results and Provides (globenewswire.com)
2026-03-31 — EX-99.1 (sec.gov)
2026-03-17 — Alcon, Lensar drop $356M acquisition deal after black eye from FTC (fiercebiotech.com)
2026-03-16 — Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement | Alcon (alcon.com)
2026-03-13 — Alcon's Lensar acquisition could be in jeopardy, analysts say (massdevice.com)
Company details
LENSAR is listed on NASDAQ under the ticker LNSR and focuses on cataract and astigmatism procedures for eye care providers. Lensar, Inc. was founded in 2004, has an estimated 100-200 employees, and is headquartered in Orlando, Florida.
Frequently asked questions
What does Lensar, Inc. make?
Lensar, Inc. is a medical device company headquartered in Orlando, Florida, founded in 2004. It employs roughly 100 to 200 people and is publicly traded on NASDAQ under the ticker LNSR. The company makes robotic femtosecond laser systems used in refractive eye surgery, serving ophthalmologists and surgical centers. Its flagship offerings include the LENSAR Laser System and the ALLY Robotic Cataract Laser System. In March 2026, Alcon and LENSAR agreed to terminate a merger agreement.
Where is Lensar, Inc. headquartered?
Lensar, Inc. is headquartered in Orlando, Florida (2800 Discovery Dr, Orlando, Florida, 32826).
When was Lensar, Inc. founded?
Lensar, Inc. was founded in 2004.
How big is Lensar, Inc.?
Lensar, Inc. has an estimated 100-200 employees, with revenue in the 58.4M range.
Is Lensar, Inc. publicly traded?
Publicly traded (NASDAQ: LNSR). Public financial figures are drawn from its filings.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
